With Fortune Korea Top 40 recognition and the ‘M.A.P. Your Health’ campaign, Orange Biomed’s novel microfluidic A1C test is transforming diabetes care. A unique opportunity to demonstrate how our ...
Attendees get an early preview of Orange Biomed’s revolutionary A1C testing method, recognized as a groundbreaking solution with anticipated release in 2025 SEATTLE ...
accuracy[1],[2] of estimated A1c algorithm in MyStar Extra(R)- At the annual meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain, Sanofi presented today the ...
(MENAFN- EIN Presswire) Award-Winning, novel Single-Cell Analysis technology in a Device Designed to Accurately Measure A1C from One Drop of Blood, Recognized by industry Experts SEATTLE, WA, UNITED ...
(MENAFN- EIN Presswire) EINPresswire/ -- Orange Biomed - the inventor of the world's first pocket-sized, microfluidic-based A1C analysis device, OBM rapid A1c - has announced its 2025 participation in ...
The estimated A1c function of MyStar Extra ® is based on a new A1c estimation method tracking average glycemia from self-monitoring data stored in the device. Scientific data presented at EASD 2013 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback